TY  - CONF

T1  - Nab-paclitaxel or docetaxel; As alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): A cost utility analysis in five European countries

JO  - VALUE HEALTH

PY  - 2008/05/01

AU  - Dranitsaris G

AU  - Lidgren M

AU  - Lundkvist J

AU  - Coleman R

ED  - 

VL  - 11

IS  - 3

SP  - A71

EP  - A71

Y2  - 2025/10/10

ER  -